[Letter: No increase of liver carcinoma following anabolic therapy].
D045930:Anabolic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy; D008113:Liver Neoplasms / Q000139:chemically induced*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged
D045930:Anabolic Agents
Lebercarcinome nach Anabolikatherapie nicht gehäuft.